Methylated p14ARF was significantly associated with tumor histology, and it was lower in ccRCC than in non-ccRCC, suggesting that p14ARF promoter methylation had a decreased risk of ccRCC; whereas methylated p16INK4A had a similar frequency in ccRCC and Non-ccRCC. This evidence concerns the gene CDKN2A and nonpapillary renal cell carcinoma.